Physician profile
Gregory Park
NPI 1255445151
$3,755.59
in general payments reported to CMS, 2019-2025
30 companies · $435 in 2025
The $435 reported for 2025 was more than what 76% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $662 · 2020: $216 · 2021: $347 · 2022: $298 · 2023: $969 · 2024: $828 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,231.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $619.49 | 2022-2025 | Xeomin |
| Abbvie INC. | $549.04 | 2022-2025 | |
| Lilly USA, LLC | $278.79 | 2019-2024 | Emgality, Reyvow |
| Vertos Medical, INC. | $241.07 | 2023-2024 | Mild Device Kit |
| Spr Therapeutics, INC | $212.21 | 2023-2024 | Sprint Pns System |
| Allergan, INC. | $198.47 | 2019-2021 | |
| Assertio Therapeutics, INC. | $195.71 | 2019-2020 | |
| Relievant Medsystems, INC. | $168.13 | 2023 | Intracept |
| Si-Bone, INC. | $125.00 | 2021 | |
| Bioventus LLC | $119.51 | 2019-2023 | Durolane |
| Nevro Corp. | $109.94 | 2023 | Senza |
| Biodelivery Sciences International, INC. | $98.96 | 2019-2021 | |
| Collegium Pharmaceutical, INC. | $97.55 | 2019-2020 | |
| Lundbeck LLC | $85.96 | 2024-2025 | Vyepti |
| Vertex Pharmaceuticals Incorporated | $80.81 | 2025 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $77.76 | 2019 | |
| Painteq LLC | $70.84 | 2024 | Painteq |
| Radius Health, INC. | $65.27 | 2019 | |
| Saol Therapeutics INC. | $53.93 | 2019-2020 | |
| Djo, LLC | $48.78 | 2024 | Cmf |
| Medtronic, INC. | $46.01 | 2024 | Intellis Adaptivestim, Synchromedii |
| Pfizer INC. | $42.80 | 2019-2020 | |
| Abbott Laboratories | $37.28 | 2019 | |
| Depuy Synthes Sales INC. | $36.64 | 2022-2023 | Monovisc, Orthovisc |
| Saluda Medical Americas, INC. | $20.25 | 2025 | Evoke |
| Ipsen Biopharmaceuticals, INC | $17.80 | 2019 | |
| Sentynl Therapeutics, INC. | $17.00 | 2019 | |
| Merz North America, INC. | $15.09 | 2019 | |
| Scilex Pharmaceuticals INC. | $14.64 | 2019 | |
| Medtronic USA, INC. | $10.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.